» Articles » PMID: 8018500

Improved Neurological Outcome in Children with Chronic Renal Disease from Infancy

Overview
Journal Pediatr Nephrol
Specialties Nephrology
Pediatrics
Date 1994 Apr 1
PMID 8018500
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Progressive encephalopathy, developmental delay, microcephaly, electroencephalogram (EEG) and computed tomographic (CT) scan abnormalities have been reported in 80% of children with chronic renal failure (CRF) in infancy. Malnutrition, aluminium intoxication and psychosocial deprivation are proposed as causes. In 15 children with CRF from infancy we evaluated the effect of no aluminium salts and early vigorous nutritional and psychosocial support, in addition to the standard therapy, on neurological development. Six patients underwent dialysis (2 at birth) and 3 received transplants. None of our patients were given aluminium therapy. The nutritional status of the patients in the first 2 years of life was assessed with the waterlow classification. At the end of the follow-up period (mean 50 months range 14-148 months), patients underwent neurodevelopmental assessment, head CT scan, EEG, nerve conduction velocity (NCV) and auditory brain stem evoked response (ABER). None of our patients developed progressive encephalopathy or recurrent seizures. All have a normal neurological examination apart from hypotonia. Microcephaly was present in 5 patients. There was a good correlation between malnutrition in the first 2 years of life and microcephaly. Developmental delay was present in 3 patients; all 3 were microcephalic. There was evidence of brain atrophy on CT scan in only 3 patients. EEG was abnormal in 6 patients, but only severe in 1 patient. Only 1 patient had diminished NCV; all patients had a normal ABER. We conclude that a policy of no oral aluminium therapy and early nutritional support leads to better neurological outcome in children with CRF from infancy.

Citing Articles

Neurodevelopmental profile of infants and toddlers awaiting a kidney transplant.

Glad D, Anzalone C, Kane-Grade F, Gu L, Evans M, Kizilbash S Pediatr Nephrol. 2024; 39(7):2187-2197.

PMID: 38285058 DOI: 10.1007/s00467-024-06282-z.


Peripheral Neuropathy in Children With Chronic Kidney Disease: Are We Looking Enough?.

Sonbhadra A, Reddy B, Saini A, Tiewsoh K, Paria P, Kesavan S Ann Indian Acad Neurol. 2022; 25(3):389-393.

PMID: 35936645 PMC: 9350774. DOI: 10.4103/aian.aian_1067_21.


Neurophysiological and Neuroradiological Changes in Children With Chronic Kidney Disease.

Abd El Naby S, Bahbah W, Kasemy Z, Mahmoud A Front Pediatr. 2020; 8:570708.

PMID: 33313023 PMC: 7701333. DOI: 10.3389/fped.2020.570708.


The brain in pediatric chronic kidney disease-the intersection of cognition, neuroimaging, and clinical biomarkers.

Harshman L, Hooper S Pediatr Nephrol. 2020; 35(12):2221-2229.

PMID: 31897717 PMC: 8493603. DOI: 10.1007/s00467-019-04417-1.


Peripheral nerve disease secondary to systemic conditions in children.

Wilmshurst J, Ouvrier R, Ryan M Ther Adv Neurol Disord. 2019; 12:1756286419866367.

PMID: 31447934 PMC: 6691669. DOI: 10.1177/1756286419866367.


References
1.
Nathan E, Pedersen S . Dialysis encephalopathy in a non-dialysed uraemic boy treated with aluminium hydroxide orally. Acta Paediatr Scand. 1980; 69(6):793-6. DOI: 10.1111/j.1651-2227.1980.tb07155.x. View

2.
Nelson K, Deutschberger J . Head size at one year as a predictor of four-year IQ. Dev Med Child Neurol. 1970; 12(4):487-95. DOI: 10.1111/j.1469-8749.1970.tb01944.x. View

3.
Randall M . Aluminium toxicity in an infant not on dialysis. Lancet. 1983; 1(8337):1327-8. DOI: 10.1016/s0140-6736(83)92433-9. View

4.
Schwartz G, Feld L, Langford D . A simple estimate of glomerular filtration rate in full-term infants during the first year of life. J Pediatr. 1984; 104(6):849-54. DOI: 10.1016/s0022-3476(84)80479-5. View

5.
Davis I, Chang P, Nevins T . Successful renal transplantation accelerates development in young uremic children. Pediatrics. 1990; 86(4):594-600. View